223 related articles for article (PubMed ID: 6136102)
21. Common gastrointestinal diseases in the elderly.
Erwin WG
Geriatrics; 1988 Dec; 43 Suppl():75-82. PubMed ID: 2903840
[TBL] [Abstract][Full Text] [Related]
22. [H2 blockers and antacids in gastrointestinal diseases].
Stein J; Rösch W
Pharm Unserer Zeit; 2007; 36(1):38-43. PubMed ID: 17283749
[No Abstract] [Full Text] [Related]
23. [Treatment of peptic ulcer with histamine H2-receptor antagonists].
Radbil' OS
Sov Med; 1977 Nov; (11):111-9. PubMed ID: 24276
[No Abstract] [Full Text] [Related]
24. Omeprazole.
Langman MJ
BMJ; 1991 Aug; 303(6801):481-2. PubMed ID: 1680515
[No Abstract] [Full Text] [Related]
25. Pharmacologic Therapies in Gastrointestinal Diseases.
Fox RK; Muniraj T
Med Clin North Am; 2016 Jul; 100(4):827-50. PubMed ID: 27235617
[TBL] [Abstract][Full Text] [Related]
26. Famotidine: postmarketing clinical experience.
Saigenji K; Fukutomi H; Nakazawa S
Scand J Gastroenterol Suppl; 1987; 134():34-40. PubMed ID: 2889256
[TBL] [Abstract][Full Text] [Related]
27. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders].
Degtiareva II; Kharchenko NV; Lodianaia EV; Zukheĭr Kh; Tokar' DV; Nevstruev VP; Piletskiĭ AM
Lik Sprava; 1995; (1-2):48-51. PubMed ID: 7483543
[TBL] [Abstract][Full Text] [Related]
28. [Medical treatment of gastroesophageal reflux by H2 receptor antagonists].
Scarpignato C; Bruley des Varannes S
Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S78-89. PubMed ID: 10078436
[No Abstract] [Full Text] [Related]
29. Innovations in peptic ulcer disease: histamine 2-receptor antagonists.
Romankiewicz N
J Pract Nurs; 1983; 33(8):8-9. PubMed ID: 6140313
[No Abstract] [Full Text] [Related]
30. [Antacids, histamine H2 receptor antagonists].
Raphaël M
Soins; 1988 Apr; (511):I-II. PubMed ID: 2899911
[No Abstract] [Full Text] [Related]
31. New drugs in gastroenterology.
Friedman G
Mt Sinai J Med; 1985 Jun; 52(6):484-9. PubMed ID: 3875031
[No Abstract] [Full Text] [Related]
32. Treating gastroesophageal reflux disease.
Long K; Long R
Nurse Pract Forum; 1994 Jun; 5(2):63-4. PubMed ID: 7912126
[No Abstract] [Full Text] [Related]
33. [Effect of M-cholinolytics and histamine H2 receptor blockaders on the acid-peptide factor in patients with peptic ulcer].
Masevich TsG; Shastina NN
Klin Med (Mosk); 1987 Oct; 65(10):73-6. PubMed ID: 2892966
[No Abstract] [Full Text] [Related]
34. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
Mainguet P
Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
[No Abstract] [Full Text] [Related]
35. [Gastroesophageal reflux (round table II)].
Lahaie R; Laroche C; Boivin M; Le Lorier J
Union Med Can; 1995 Mar; 124(1):32-6. PubMed ID: 8540150
[No Abstract] [Full Text] [Related]
36. [A gastroenterologist's choice: proton pump inhibitors of H2 histamine receptor blockers in the treatment of peptic ulcer].
Morozov IA
Klin Med (Mosk); 2001; 79(5):68-71. PubMed ID: 11510196
[No Abstract] [Full Text] [Related]
37. [Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists].
Lorusso D; Pezzolla F; Lantone G; Misciagna G; Guerra V
Minerva Chir; 1997 Nov; 52(11):1293-7. PubMed ID: 9489325
[TBL] [Abstract][Full Text] [Related]
38. H2-blocker therapy and necrotizing enterocolitis for very low birth weight preterm infants.
Lin HC; Su BH; Chen AC
Pediatrics; 2006 Oct; 118(4):1794-5; author reply 1795-6. PubMed ID: 17015576
[No Abstract] [Full Text] [Related]
39. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Leite LP; Just RJ; Castell DO; Lagerström PO
Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
[TBL] [Abstract][Full Text] [Related]
40. [Medical treatment of gastroesophageal reflux in adults].
Cadiot G
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):100-2. PubMed ID: 8737506
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
